Glucose iAUC (OGTT)
L-citrulline supplementation (Phase 1) → Glucose iAUC (OGTT)
L-citrulline supplementation (Phase 1) → Glucose iAUC (OGTT)
Evidence profile
Key finding
CITS increased the LnRHI (Δ0.11 ± 0.16 vs. Δ−0.08 ± 0.24, p < 0.05)
Citrulline supplementation improved microvascular function and muscle strength in patients with type 2 diabetes compared to placebo.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Citrulline supplementation, Placebo
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Primary outcome
Log-transformed reactive hyperemia index (LnRHI)
Comparator
Placebo
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
Citrulline supplementation improved microvascular function and muscle strength in patients with type 2 diabetes compared to placebo.
Improving microvascular function and muscle strength in patients with type 2 diabetes can enhance overall health and reduce complications associated with the disease. Citrulline supplementation may offer a simple, effective strategy to support these improvements, potentially leading to better management of diabetes-related issues.
Limited sample size may affect generalizability. Short duration of the study may not capture long-term effects. Potential confounding factors not fully controlled.
Published in
Publication details and source links for this paper.
Arturo F, Katherine ND, Danielle EL, Yejin K, Carlo MP. Citrulline Supplementation Improves Microvascular Function and Muscle Strength in Patients with Type 2 Diabetes. Nutrients. 2025;17(17):2790. doi:10.3390/nu17172790
Save this study and add notes to your research library.
Citrulline supplementation increased the LnRHI by Δ0.11 ± 0.16 (p < 0.05).
Citrulline supplementation increased the TOI range by Δ2.6 ± 3.3% (p < 0.01).
Citrulline supplementation increased calf muscle strength by Δ1.5 ± 2.8 kg (p < 0.05).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to L-citrulline supplementation (Phase 1) and Glucose iAUC (OGTT), Log-transformed reactive hyperemia index (LnRHI), Muscular strength, and 3 more.
This study contributes evidence to
Primary intervention
L-citrulline supplementation (Phase 1)
Primary outcomes
Evidence topics
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
1
Related topics
6
Evidence pairs
109
Related studies
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
L-citrulline supplementation (Phase 1) → Glucose iAUC (OGTT)
L-citrulline supplementation (Phase 1) → Glucose iAUC (OGTT)
Evidence profile
L-citrulline supplementation (Phase 1) → Log-transformed reactive hyperemia index (LnRHI)
L-citrulline supplementation (Phase 1) → Log-transformed reactive hyperemia index (LnRHI)
Evidence profile
L-citrulline supplementation (Phase 1) → Muscular strength
L-citrulline supplementation (Phase 1) → Muscular strength
Evidence profile
L-citrulline supplementation (Phase 1) → Plasma arginine levels
L-citrulline supplementation (Phase 1) → Plasma arginine levels
Evidence profile
L-citrulline supplementation (Phase 1) → Tissue Oxygen Index (TOI) Range
L-citrulline supplementation (Phase 1) → Tissue Oxygen Index (TOI) Range
Evidence profile
L-citrulline supplementation (Phase 1) → TOI hyperemic response
L-citrulline supplementation (Phase 1) → TOI hyperemic response
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
This study contributes to evidence on L-citrulline supplementation (Phase 1) and Log-transformed reactive hyperemia index (LnRHI), L-citrulline supplementation (Phase 1) and Muscular Strength.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies on L-citrulline supplementation (Phase 1)
Contributes to L-citrulline supplementation (Phase 1) evidence base.
All studies measuring Log-transformed reactive hyperemia index (LnRHI)
Measures Log-transformed reactive hyperemia index (LnRHI) as a key outcome.
All studies measuring Muscular Strength
Measures Muscular Strength as a key outcome.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
1 results
1 results
L-citrulline supplementation (Phase 1) appears to improve Muscular strength.
ConsensusScore™: Results are consistent across studies.
Ranked evidence signals
Muscular strength
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
L-citrulline supplementation (Phase 1) appears to improve Log-transformed reactive hyperemia index (LnRHI).
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Log-transformed reactive hyperemia index (LnRHI)
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
L-citrulline supplementation (Phase 1) appears to improve Plasma arginine levels.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Plasma arginine levels
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
L-citrulline supplementation (Phase 1) appears to improve TOI hyperemic response.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
TOI hyperemic response
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.